Skip to content

Effects of Exercise Timing on Sleep Quality

Effects of Exercise Timing and Physical Activity Level on Sleep Quality and Body Temperature

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07322276
Acronym
SLEEPCORE
Enrollment
42
Registered
2026-01-07
Start date
2026-01-23
Completion date
2029-05-31
Last updated
2026-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Endurance Athlet, Inactive People

Keywords

endurance athletes, exercise timing, sleep quality

Brief summary

Modern lifestyles are marked by a prevalence of sedentary behaviors and physical inactivity, which have been linked to numerous adverse health effects. While regular physical exercise is a well-established countermeasure, exercising in the late afternoon may paradoxically disrupt deep sleep due to increased core body temperature. Inactive and sedentary individuals, who often have impaired autonomic function compared to endurance-trained athletes, may be particularly susceptible to these negative effects, potentially resulting in compromised thermoregulation and exacerbated disruptions to deep sleep, a critical stage of sleep essential for overall recovery. Therefore, this study aims to investigate the impact of aerobic exercise performed in the late afternoon versus morning on: 1) deep sleep and sleep onset latency; and 2) core body temperature and its autonomic regulatory mechanisms on endurance-trained and inactive-sedentary people.

Interventions

OTHERAerobic Exercise

The exercise consists of running on a treadmill at 90% of maximum aerobic speed (MAS) for 30 minutes, followed by 12% increments every 5 minutes, until exhaustion (a "time-to-exhaustion" type of exercise).

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

This is a single-center, open-label, randomized controlled trial with two parallel crossover groups: * "Active" group * "Inactive-sedentary" group

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Group "Inactive" :No regular exercise practice (inactive people that don't follow the WHO recommendations) and have sedentary behaviors * Group "Active": Regular exercise (athletes that are specialized in aerobic exercise, with more than 300 minutes per-week over 6 months and practice at regional level).

Exclusion criteria

* Have sleep disorders medically diagnosed or detected by sleep forms cutoffs (clinical insomnia by ISI, severe risk of obstructive sleep apnea by Stop-Bang, bad sleep quality by PSQI. * Have a diagnosed mental health condition requiring treatment * Have renal, respiratory, cardiovascular or neuromuscular disease medically diagnosed. * Be pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Duration of deep slow-wave sleepOnce a month for 3 monthsEvaluation of the duration of deep slow-wave sleep (N3 stage) quantified by the EEG signal from polysomnography (Nox A1, Resmed®, USA).

Secondary

MeasureTime frameDescription
Assessment of core temperatureOnce a month for 3 monthsAssessment of core temperature until the end of the sleep period will be measured using gastrointestinal telemetric pills (eCelsius, Bodycap®, France).
Evaluation of autonomic nervous system thermoregulationOnce a month for 3 monthsEvaluation of autonomic nervous system thermoregulation through time-domain (R-R intervals in ms)
Complementary sleep evaluationOnce a month for 3 monthsComplementary sleep evaluation through analysis of duration of N1, N2, and REM stages (in Percentage of Total Sleep Time)

Countries

France

Contacts

CONTACTFrédéric ROCHE, PhD
frederic.roche@univ-st-etienne.fr0477828695
PRINCIPAL_INVESTIGATORFrédéric ROCHE, PhD

Centre Hospitalier Universitaire de Saint Etienne

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 4, 2026